Global Pharmaceutical Contract Manufacture Organization Market Size, Status and Forecast 2019-2025

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by Pharmaceutical Contract Manufacture Organization Revenue
• 1.4 Market by Type
  • 1.4.1 Global Pharmaceutical Contract Manufacture Organization Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 Active Pharmaceutical Ingredients (APIs)
  • 1.4.3 Finished Dose Formulations (FDFs)
• 1.5 Market by Application
  • 1.5.1 Global Pharmaceutical Contract Manufacture Organization Market Share by Application: 2020 VS 2026
  • 1.5.2 Specialty/Midsize
  • 1.5.3 Generics
  • 1.5.4 Big Pharma
  • 1.5.5 Other
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends

• 2.1 Global Pharmaceutical Contract Manufacture Organization Market Perspective (2015-2026)
• 2.2 Global Pharmaceutical Contract Manufacture Organization Growth Trends by Regions
  • 2.2.1 Pharmaceutical Contract Manufacture Organization Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Pharmaceutical Contract Manufacture Organization Historic Market Share by Regions (2015-2020)
  • 2.2.3 Pharmaceutical Contract Manufacture Organization Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 Pharmaceutical Contract Manufacture Organization Market Growth Strategy
  • 2.3.6 Primary Interviews with Key Pharmaceutical Contract Manufacture Organization Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top Pharmaceutical Contract Manufacture Organization Players by Market Size
  • 3.1.1 Global Top Pharmaceutical Contract Manufacture Organization Players by Revenue (2015-2020)
  • 3.1.2 Global Pharmaceutical Contract Manufacture Organization Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global Pharmaceutical Contract Manufacture Organization Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global Pharmaceutical Contract Manufacture Organization Market Concentration Ratio
  • 3.2.1 Global Pharmaceutical Contract Manufacture Organization Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by Pharmaceutical Contract Manufacture Organization Revenue in 2019
• 3.3 Pharmaceutical Contract Manufacture Organization Key Players Head office and Area Served
• 3.4 Key Players Pharmaceutical Contract Manufacture Organization Product Solution and Service
• 3.5 Date of Enter into Pharmaceutical Contract Manufacture Organization Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

• 4.1 Global Pharmaceutical Contract Manufacture Organization Historic Market Size by Type (2015-2020)
• 4.2 Global Pharmaceutical Contract Manufacture Organization Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

• 5.1 Global Pharmaceutical Contract Manufacture Organization Market Size by Application (2015-2020)
• 5.2 Global Pharmaceutical Contract Manufacture Organization Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Pharmaceutical Contract Manufacture Organization Market Size (2015-2020)
• 6.2 Pharmaceutical Contract Manufacture Organization Key Players in North America (2019-2020)
• 6.3 North America Pharmaceutical Contract Manufacture Organization Market Size by Type (2015-2020)
• 6.4 North America Pharmaceutical Contract Manufacture Organization Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe Pharmaceutical Contract Manufacture Organization Market Size (2015-2020)
• 7.2 Pharmaceutical Contract Manufacture Organization Key Players in Europe (2019-2020)
• 7.3 Europe Pharmaceutical Contract Manufacture Organization Market Size by Type (2015-2020)
• 7.4 Europe Pharmaceutical Contract Manufacture Organization Market Size by Application (2015-2020)

8 China

• 8.1 China Pharmaceutical Contract Manufacture Organization Market Size (2015-2020)
• 8.2 Pharmaceutical Contract Manufacture Organization Key Players in China (2019-2020)
• 8.3 China Pharmaceutical Contract Manufacture Organization Market Size by Type (2015-2020)
• 8.4 China Pharmaceutical Contract Manufacture Organization Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan Pharmaceutical Contract Manufacture Organization Market Size (2015-2020)
• 9.2 Pharmaceutical Contract Manufacture Organization Key Players in Japan (2019-2020)
• 9.3 Japan Pharmaceutical Contract Manufacture Organization Market Size by Type (2015-2020)
• 9.4 Japan Pharmaceutical Contract Manufacture Organization Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia Pharmaceutical Contract Manufacture Organization Market Size (2015-2020)
• 10.2 Pharmaceutical Contract Manufacture Organization Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia Pharmaceutical Contract Manufacture Organization Market Size by Type (2015-2020)
• 10.4 Southeast Asia Pharmaceutical Contract Manufacture Organization Market Size by Application (2015-2020)

11 India

• 11.1 India Pharmaceutical Contract Manufacture Organization Market Size (2015-2020)
• 11.2 Pharmaceutical Contract Manufacture Organization Key Players in India (2019-2020)
• 11.3 India Pharmaceutical Contract Manufacture Organization Market Size by Type (2015-2020)
• 11.4 India Pharmaceutical Contract Manufacture Organization Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America Pharmaceutical Contract Manufacture Organization Market Size (2015-2020)
• 12.2 Pharmaceutical Contract Manufacture Organization Key Players in Central & South America (2019-2020)
• 12.3 Central & South America Pharmaceutical Contract Manufacture Organization Market Size by Type (2015-2020)
• 12.4 Central & South America Pharmaceutical Contract Manufacture Organization Market Size by Application (2015-2020)

13 Key Players Profiles

• 13.1 Lonza
  • 13.1.1 Lonza Company Details
  • 13.1.2 Lonza Business Overview
  • 13.1.3 Lonza Pharmaceutical Contract Manufacture Organization Introduction
  • 13.1.4 Lonza Revenue in Pharmaceutical Contract Manufacture Organization Business (2015-2020))
  • 13.1.5 Lonza Recent Development
• 13.2 Boehringer Ingelheim
  • 13.2.1 Boehringer Ingelheim Company Details
  • 13.2.2 Boehringer Ingelheim Business Overview
  • 13.2.3 Boehringer Ingelheim Pharmaceutical Contract Manufacture Organization Introduction
  • 13.2.4 Boehringer Ingelheim Revenue in Pharmaceutical Contract Manufacture Organization Business (2015-2020)
  • 13.2.5 Boehringer Ingelheim Recent Development
• 13.3 Catalent
  • 13.3.1 Catalent Company Details
  • 13.3.2 Catalent Business Overview
  • 13.3.3 Catalent Pharmaceutical Contract Manufacture Organization Introduction
  • 13.3.4 Catalent Revenue in Pharmaceutical Contract Manufacture Organization Business (2015-2020)
  • 13.3.5 Catalent Recent Development
• 13.4 Baxter
  • 13.4.1 Baxter Company Details
  • 13.4.2 Baxter Business Overview
  • 13.4.3 Baxter Pharmaceutical Contract Manufacture Organization Introduction
  • 13.4.4 Baxter Revenue in Pharmaceutical Contract Manufacture Organization Business (2015-2020)
  • 13.4.5 Baxter Recent Development
• 13.5 AbbVie
  • 13.5.1 AbbVie Company Details
  • 13.5.2 AbbVie Business Overview
  • 13.5.3 AbbVie Pharmaceutical Contract Manufacture Organization Introduction
  • 13.5.4 AbbVie Revenue in Pharmaceutical Contract Manufacture Organization Business (2015-2020)
  • 13.5.5 AbbVie Recent Development
• 13.6 Pfizer
  • 13.6.1 Pfizer Company Details
  • 13.6.2 Pfizer Business Overview
  • 13.6.3 Pfizer Pharmaceutical Contract Manufacture Organization Introduction
  • 13.6.4 Pfizer Revenue in Pharmaceutical Contract Manufacture Organization Business (2015-2020)
  • 13.6.5 Pfizer Recent Development
• 13.7 Evonik
  • 13.7.1 Evonik Company Details
  • 13.7.2 Evonik Business Overview
  • 13.7.3 Evonik Pharmaceutical Contract Manufacture Organization Introduction
  • 13.7.4 Evonik Revenue in Pharmaceutical Contract Manufacture Organization Business (2015-2020)
  • 13.7.5 Evonik Recent Development
• 13.8 Fareva group
  • 13.8.1 Fareva group Company Details
  • 13.8.2 Fareva group Business Overview
  • 13.8.3 Fareva group Pharmaceutical Contract Manufacture Organization Introduction
  • 13.8.4 Fareva group Revenue in Pharmaceutical Contract Manufacture Organization Business (2015-2020)
  • 13.8.5 Fareva group Recent Development
• 13.9 Aenova
  • 13.9.1 Aenova Company Details
  • 13.9.2 Aenova Business Overview
  • 13.9.3 Aenova Pharmaceutical Contract Manufacture Organization Introduction
  • 13.9.4 Aenova Revenue in Pharmaceutical Contract Manufacture Organization Business (2015-2020)
  • 13.9.5 Aenova Recent Development
• 13.10 Almac
  • 13.10.1 Almac Company Details
  • 13.10.2 Almac Business Overview
  • 13.10.3 Almac Pharmaceutical Contract Manufacture Organization Introduction
  • 13.10.4 Almac Revenue in Pharmaceutical Contract Manufacture Organization Business (2015-2020)
  • 13.10.5 Almac Recent Development
• 13.11 Delpharm
  • 10.11.1 Delpharm Company Details
  • 10.11.2 Delpharm Business Overview
  • 10.11.3 Delpharm Pharmaceutical Contract Manufacture Organization Introduction
  • 10.11.4 Delpharm Revenue in Pharmaceutical Contract Manufacture Organization Business (2015-2020)
  • 10.11.5 Delpharm Recent Development
• 13.12 Recipharm
  • 10.12.1 Recipharm Company Details
  • 10.12.2 Recipharm Business Overview
  • 10.12.3 Recipharm Pharmaceutical Contract Manufacture Organization Introduction
  • 10.12.4 Recipharm Revenue in Pharmaceutical Contract Manufacture Organization Business (2015-2020)
  • 10.12.5 Recipharm Recent Development
• 13.13 Aesica
  • 10.13.1 Aesica Company Details
  • 10.13.2 Aesica Business Overview
  • 10.13.3 Aesica Pharmaceutical Contract Manufacture Organization Introduction
  • 10.13.4 Aesica Revenue in Pharmaceutical Contract Manufacture Organization Business (2015-2020)
  • 10.13.5 Aesica Recent Development
• 13.14 NIPRO CORPORATION
  • 10.14.1 NIPRO CORPORATION Company Details
  • 10.14.2 NIPRO CORPORATION Business Overview
  • 10.14.3 NIPRO CORPORATION Pharmaceutical Contract Manufacture Organization Introduction
  • 10.14.4 NIPRO CORPORATION Revenue in Pharmaceutical Contract Manufacture Organization Business (2015-2020)
  • 10.14.5 NIPRO CORPORATION Recent Development
• 13.15 Daito Pharmaceutical
  • 10.15.1 Daito Pharmaceutical Company Details
  • 10.15.2 Daito Pharmaceutical Business Overview
  • 10.15.3 Daito Pharmaceutical Pharmaceutical Contract Manufacture Organization Introduction
  • 10.15.4 Daito Pharmaceutical Revenue in Pharmaceutical Contract Manufacture Organization Business (2015-2020)
  • 10.15.5 Daito Pharmaceutical Recent Development
• 13.16 Teva API
  • 10.16.1 Teva API Company Details
  • 10.16.2 Teva API Business Overview
  • 10.16.3 Teva API Pharmaceutical Contract Manufacture Organization Introduction
  • 10.16.4 Teva API Revenue in Pharmaceutical Contract Manufacture Organization Business (2015-2020)
  • 10.16.5 Teva API Recent Development
• 13.17 Esteve Quimica
  • 10.17.1 Esteve Quimica Company Details
  • 10.17.2 Esteve Quimica Business Overview
  • 10.17.3 Esteve Quimica Pharmaceutical Contract Manufacture Organization Introduction
  • 10.17.4 Esteve Quimica Revenue in Pharmaceutical Contract Manufacture Organization Business (2015-2020)
  • 10.17.5 Esteve Quimica Recent Development
• 13.18 Euticals
  • 10.18.1 Euticals Company Details
  • 10.18.2 Euticals Business Overview
  • 10.18.3 Euticals Pharmaceutical Contract Manufacture Organization Introduction
  • 10.18.4 Euticals Revenue in Pharmaceutical Contract Manufacture Organization Business (2015-2020)
  • 10.18.5 Euticals Recent Development
• 13.19 Zhejiang Hisun Pharmaceuticals
  • 10.19.1 Zhejiang Hisun Pharmaceuticals Company Details
  • 10.19.2 Zhejiang Hisun Pharmaceuticals Business Overview
  • 10.19.3 Zhejiang Hisun Pharmaceuticals Pharmaceutical Contract Manufacture Organization Introduction
  • 10.19.4 Zhejiang Hisun Pharmaceuticals Revenue in Pharmaceutical Contract Manufacture Organization Business (2015-2020)
  • 10.19.5 Zhejiang Hisun Pharmaceuticals Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer